BrainASAP

Peptide PHDP5 May Reverse Cognitive Impairment in Alzheimers Disease (2024 Research)

by

TLDR: Researchers demonstrated that intranasal administration of the peptide FITC-PHDP5-CPP reverses early cognitive impairment in Alzheimer’s disease (AD) model mice, showing potential as a treatment for AD-associated cognitive decline. Highlights: PHDP5, derived from the pleckstrin homology domain of dynamin 1, inhibits the interaction between dynamin and microtubules, rescuing synaptic dysfunction caused by tau accumulation. The …

Read more

Alpha Closed-Loop Auditory Stimulation Increases Alpha Brain Waves & Alters Sleep (2024 Study)

by

TLDR: A new method using sound to influence brain waves can help manage brain activity and affect how we fall asleep. Highlights: How It Works: This method, called Alpha Closed-Loop Auditory Stimulation (αCLAS), uses sound pulses timed precisely to brain waves to change brain activity. Phase Matters: The timing of the sound pulses is crucial; …

Read more

High Salt Intake Linked to Alzheimers Disease & Dementia Risk in Europeans (2024 Study)

by

TLDR: This study provides evidence that high salt intake is causally associated with an increased risk of developing dementia, including Alzheimer’s disease (AD) and undefined dementia. Highlights: Causal Association: High salt intake is significantly associated with an increased risk of any dementia (OR = 1.73) and specifically Alzheimer’s disease (OR = 2.10). Cognitive Performance: Higher …

Read more

Myopia Linked to High Screen Time in Children & Adolescents (2024 Study)

by

TLDR: High screen time exposure is significantly associated with an increased risk of myopia in children and adolescents, with computer use showing the strongest correlation, followed by television, while smartphone use shows no significant association. Highlights: Significant Link: The meta-analysis revealed a statistically significant correlation between high screen time exposure and increased risk of myopia …

Read more

Alcohol & Depression: Occasional Drinking May Lower Risk, Frequent Drinking Increases It (2024 Study)

by

TLDR: Occasional drinking may help reduce the risk of major depression, but frequent drinking worsens it. Highlights: Occasional alcohol consumption is linked to a lower risk of major depression. Frequent alcohol intake increases the risk of major depression. The risk increase from frequent drinking persists even when different types of alcohol are considered. The impact …

Read more

Omega 3 Fatty Acids May Improve Anxiety Symptoms (2024 Meta-Analysis)

by

TLDR: Omega-3 supplementation shows potential for reducing anxiety symptoms, with the most significant improvement at a dose of 2 grams per day. Highlights: Dose-Dependent Effect: Each 1 gram per day of omega-3 supplementation led to a moderate decrease in anxiety symptoms, with the greatest improvement observed at 2 grams per day. Analysis: The meta-analysis included …

Read more

Case Report: 10,000 mg Clozapine Overdose in 71-Year-Old Female (2024)

by

TLDR: This case study reports the highest recorded nonfatal clozapine overdose (10,000 mg) in an elderly patient, causing significant fluctuations in blood concentration levels following treatment. Highlights: A 71-year-old female ingested 10,000 mg of clozapine, significantly above typical overdose levels, leading to an initial blood concentration of 5200 μg/L. Despite initial treatment, blood clozapine levels …

Read more

Quercetin Alginate Nanogels Loaded with BDNF for Depression (2023 Study)

by

TLDR: Quercetin-based alginate nanogels loaded with brain-derived neurotrophic factor (BDNF) can effectively cross the blood-brain barrier via intranasal delivery, providing a promising treatment for depressive disorders. Highlights: Nanogels: Quercetin nanogels protect BDNF from oxidative damage, exhibit rapid brain distribution, and significantly enhance bioavailability compared to oral administration. Efficacy: BDNF-Quercetin nanogels delivered via intranasal route show …

Read more

Severe COVID Anxiety in UK Adults Treated with CBT-HA (2024 Study)

by

TLDR: A study in the UK found that severe COVID anxiety tends to decrease over 6 months from onset, both organically and with the help of CBT for Health Anxiety (CBT-HA), though many individuals still experience significant anxiety and poor social functioning, with health anxiety being a key factor that can be effectively targeted with …

Read more

Esketamine Nasal Spray Rapidly Treats Depression & Suicidal Ideation (2023 Study)

by

TLDR: Esketamine nasal spray, combined with standard antidepressant therapy, significantly improves remission rates and reduces time to remission in adults with major depressive disorder (MDD) and acute suicidality compared to standard care alone. Highlights: Remission Rates: Patients treated with esketamine plus standard of care had higher remission rates than those treated with placebo plus standard …

Read more

+ Load more